Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Ruri, Abe"'
Autor:
Takahide Fujihashi, Yasuhiko Sakata, Kotaro Nochioka, Masanobu Miura, Ruri Abe, Shintaro Kasahara, Masayuki Sato, Hajime Aoyanagi, Shinsuke Yamanaka, Hideka Hayashi, Takashi Shiroto, Koichiro Sugimura, Jun Takahashi, Satoshi Miyata, Hiroaki Shimokawa, CHART‐2 Investigators
Publikováno v:
ESC Heart Failure, Vol 8, Iss 2, Pp 1027-1038 (2021)
Abstract Aims Prognostic impacts of serum uric acid (UA) levels in patients with chronic heart failure (CHF) remain inconclusive, especially for the whole range of serum UA levels. Methods and results In the Chronic Heart Failure Registry and Analysi
Externí odkaz:
https://doaj.org/article/9288cdef20f04080bb310720f7e47d14
Autor:
Masayuki Sato, Yasuhiko Sakata, Kenjiro Sato, Kotaro Nochioka, Masanobu Miura, Ruri Abe, Takuya Oikawa, Shintaro Kasahara, Hajime Aoyanagi, Shinsuke Yamanaka, Takahide Fujihashi, Hideka Hayashi, Takashi Shiroto, Koichiro Sugimura, Jun Takahashi, Satoshi Miyata, Hiroaki Shimokawa
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 27, Iss , Pp - (2020)
Background: Since most of the randomized clinical trials for heart failure (HF) were designed to exclude elderly patients, limited data are available on their clinical characteristics, prognosis, and prognostic factors. Methods: We compared clinical
Externí odkaz:
https://doaj.org/article/2318d2414f9b471ebd54b09c218ffd2d
Autor:
Takuya Oikawa, Yasuhiko Sakata, Kotaro Nochioka, Masanobu Miura, Kanako Tsuji, Takeo Onose, Ruri Abe, Shintaro Kasahara, Masayuki Sato, Takashi Shiroto, Jun Takahashi, Satoshi Miyata, Hiroaki Shimokawa
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 6 (2018)
BackgroundThe beneficial prognostic impact of statins has been established in patients with ischemic heart disease but not in those with heart failure (HF). In addition, it is still unclear whether patients benefit from statins regardless of low‐de
Externí odkaz:
https://doaj.org/article/9b7d027b618a466bb61ccbf91981966f
Autor:
Masanobu Miura, Yasuhiko Sakata, Masayuki Sato, Ruri Abe, Chart Investigators, Takashi Shiroto, Koichiro Sugimura, Kotaro Nochioka, Takahide Fujihashi, Hajime Aoyanagi, Jun Takahashi, Hideka Hayashi, Shinsuke Yamanaka, Shintaro Kasahara, Satoshi Miyata, Hiroaki Shimokawa
Publikováno v:
ESC Heart Failure, Vol 8, Iss 2, Pp 1027-1038 (2021)
ESC Heart Failure
ESC Heart Failure
Aims Prognostic impacts of serum uric acid (UA) levels in patients with chronic heart failure (CHF) remain inconclusive, especially for the whole range of serum UA levels. Methods and results In the Chronic Heart Failure Registry and Analysis in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::572a3b2a4609a926cee036b3d82c63b9
https://doi.org/10.1002/ehf2.12765
https://doi.org/10.1002/ehf2.12765
Autor:
Satoshi Miyata, Hiroaki Shimokawa, Ruri Abe, Yasuhiko Sakata, Shintaro Kasahara, Kotaro Nochioka, Masayuki Sato, Kota Suzuki, Hajime Aoyanagi, Shinsuke Yamanaka, Jun Takahashi, Takashi Shiroto, Koichiro Sugimura, Masanobu Miura, Tsuyoshi Takada, Takahide Fujihashi
Publikováno v:
International Journal of Cardiology. 307:87-93
Aims Asymptomatic patients with structural heart diseases are classified as a population at high risk for heart failure (HF) in Stage B. However, limited data are available regarding incidence and related factors of de-novo HF (DNHF) considering comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cdfd044f192af7eabaea5968ae2a862
https://doi.org/10.1016/j.ijcard.2020.02.015
https://doi.org/10.1016/j.ijcard.2020.02.015
Autor:
Masanobu Miura, Chart Investigators, Ruri Abe, Yasuhiko Sakata, Masayuki Sato, Hideka Hayashi, Hajime Aoyanagi, Satoshi Miyata, Shintaro Kasahara, Jun Takahashi, Takahide Fujihashi, Kotaro Nochioka, Koichiro Sugimura, Shinsuke Yamanaka, Hiroaki Shimokawa, Takashi Shiroto
Publikováno v:
International Journal of Cardiology. 306:123-132
Background We have recently demonstrated that left ventricular ejection fraction (LVEF) dynamically changes over time with prognostic impacts in Stage C/D patients, namely, those who have a current or past history of heart failure (HF). However, it i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab5a6f8aee0b9b0971483478ad2a2634
https://doi.org/10.1016/j.ijcard.2020.02.040
https://doi.org/10.1016/j.ijcard.2020.02.040
Autor:
Ruri Abe, Takahide Fujihashi, Masanobu Miura, Hiroaki Shimokawa, Masayuki Sato, Yasuhiko Sakata, Satoshi Miyata, Kotaro Nochioka, Hajime Aoyanagi, Hideka Hayashi, Shintaro Kasahara, Jun Takahashi, Shinsuke Yamanaka, Takashi Shiroto
Publikováno v:
International Journal of Cardiology. 299:160-168
Background The benefits of antithrombotic therapy (ATT) for atrial fibrillation (AF) are occasionally offset by major bleeding complications. However, the clinical benefits and risks of ATT in AF patients, with special references to comorbidities, su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdf51f8ccb7aa4e9d686821c33fe9776
https://doi.org/10.1016/j.ijcard.2019.09.022
https://doi.org/10.1016/j.ijcard.2019.09.022
Autor:
Chart Investigators, Yasuko Ikeno, Yasuhiko Sakata, Masanobu Miura, Takuya Oikawa, Masayuki Sato, Takashi Shiroto, Hajime Aoyanagi, Shintaro Kasahara, Jun Takahashi, Chiharu Saga, Ruri Abe, Koichiro Sugimura, Kotaro Nochioka, Satoshi Miyata, Hiroaki Shimokawa
Publikováno v:
International Journal of Cardiology. 293:17-24
Several studies have reported that C-reactive protein (CRP), an inflammatory biomarker, predicts cardiovascular events independently of low-density lipoprotein cholesterol levels. However, no study examined whether temporal changes in CRP levels are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89d9ecf9bee818d0f51daf7551451f8e
https://doi.org/10.1016/j.ijcard.2019.07.022
https://doi.org/10.1016/j.ijcard.2019.07.022
Autor:
Masanobu Miura, Chart Investigators, Yasuhiko Sakata, Ruri Abe, Kotaro Nochioka, Takashi Shiroto, Shintaro Kasahara, Koichiro Sugimura, Masayuki Sato, Satoshi Miyata, Hiroaki Shimokawa, Hajime Aoyanagi, Jun Takahashi, Takuya Oikawa
Publikováno v:
International Journal of Cardiology. 290:106-112
Although several factors, including heart failure (HF) and inflammation, are known to increase the incidence of cancer, it remains unknown whether HF may increase cancer mortality, especially with a reference to inflammation.We examined 8843 consecut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f6916b37fa74a03a28f042895ed68ce
https://doi.org/10.1016/j.ijcard.2019.04.078
https://doi.org/10.1016/j.ijcard.2019.04.078
Autor:
Yasuhiko Sakata, Brian Claggett, Koichiro Sugimura, Tiew-Hwa Katherine Teng, Takashi Shiroto, Satoshi Miyata, Wan Ting Tay, Takuya Oikawa, Ruri Abe, Hajime Aoyanagi, Masanobu Miura, Hiroaki Shimokawa, Jun Takahashi, Shintaro Kasahara, Kotaro Nochioka, Masayuki Sato
Publikováno v:
International Journal of Cardiology. 284:42-49
Background Few simple risk models, without echocardiography have been developed for patients with heart failure (HF) and preserved left ventricular ejection fraction (LVEF) (HFpEF). Methods To develop a risk score to predict all-cause death for HFpEF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b5ad22cef262ea663f5a16b2bfa6212
https://doi.org/10.1016/j.ijcard.2018.10.076
https://doi.org/10.1016/j.ijcard.2018.10.076